Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
出版年份 2019 全文链接
标题
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
作者
关键词
<em class="EmphasisTypeItalic ">Fusobacterium nucleatum</em>, BIRC3, 5-fluorouracil, Chemoresistance, Colorectal cancer
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-10
DOI
10.1186/s13046-018-0985-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway
- (2018) Linlin Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The gut microbiota influences anticancer immunosurveillance and general health
- (2018) Bertrand Routy et al. Nature Reviews Clinical Oncology
- Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
- (2018) Sheng Zhang et al. Journal of Cancer
- Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21
- (2017) Yongzhi Yang et al. GASTROENTEROLOGY
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Microbiome and Anticancer Immunosurveillance
- (2016) Laurence Zitvogel et al. CELL
- Endothelial Cell Response to Fusobacterium nucleatum
- (2016) Reila Tainá Mendes et al. INFECTION AND IMMUNITY
- Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle
- (2016) Valeria García-Castillo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis
- (2015) Kosuke Mima et al. GUT
- Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
- (2015) Chamutal Gur et al. IMMUNITY
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
- (2014) T. Tahara et al. CANCER RESEARCH
- Gastrointestinal Malignancy and the Microbiome
- (2014) Maria T. Abreu et al. GASTROENTEROLOGY
- The multiple facets of drug resistance: one history, different approaches
- (2014) Evandro Niero et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The gut microbiota, bacterial metabolites and colorectal cancer
- (2014) Petra Louis et al. NATURE REVIEWS MICROBIOLOGY
- Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
- (2013) Mara Roxana Rubinstein et al. Cell Host & Microbe
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
- (2013) Na Wu et al. MICROBIAL ECOLOGY
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA
- (2011) Feng Wang et al. CANCER LETTERS
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
- (2011) M. Castellarin et al. GENOME RESEARCH
- Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer
- (2011) Koh Miura et al. SURGERY TODAY
- Survivin and IAP proteins in cell-death mechanisms
- (2010) Dario C. Altieri BIOCHEMICAL JOURNAL
- Challenges of drug resistance in the management of pancreatic cancer
- (2010) Rizwan Sheikh et al. Expert Review of Anticancer Therapy
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells
- (2009) Hideaki Karasawa et al. CANCER SCIENCE
- cIAP2 as a therapeutic target in colorectal cancer and other malignancies
- (2009) Koh Miura et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms
- (2008) Zhiwei Xu et al. TOXICOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started